Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization
Status:
Unknown status
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate, compared to non-treatment, the impact of
a titrated dose (1 mg once a day, then 1 mg twice a day and finally a full 2 mg twice a day)
of ketotifen on the adverse event profile emerging from a rapid peanut desensitization
protocol, in children with established peanut allergy.